Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

699 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Novel developments in the use of antimetabolites.
Peters GJ. Peters GJ. Nucleosides Nucleotides Nucleic Acids. 2014;33(4-6):358-74. doi: 10.1080/15257770.2014.894197. Nucleosides Nucleotides Nucleic Acids. 2014. PMID: 24940694 Review.
Protection by WR-2721 of the toxicity induced by the combination of cisplatin and 5-fluorouracil.
Peters GJ, van der Wilt CL, Gyergyay F, van Laar JA, Treskes M, van der Vijgh WJ, Pinedo HM. Peters GJ, et al. Int J Radiat Oncol Biol Phys. 1992;22(4):785-9. doi: 10.1016/0360-3016(92)90524-l. Int J Radiat Oncol Biol Phys. 1992. PMID: 1312075
In vitro and in vivo studies on the combination of Brequinar sodium (DUP-785; NSC 368390) with 5-fluorouracil; effects of uridine.
Peters GJ, Kraal I, Pinedo HM. Peters GJ, et al. Br J Cancer. 1992 Feb;65(2):229-33. doi: 10.1038/bjc.1992.46. Br J Cancer. 1992. PMID: 1739622 Free PMC article.
Concentration and time dependent growth inhibition and metabolism in vitro by 2',2'-difluoro-deoxycytidine (gemcitabine).
Ruiz van Haperen VW, Veerman G, Noordhuis P, Vermorken JB, Peters GJ. Ruiz van Haperen VW, et al. Among authors: peters gj. Adv Exp Med Biol. 1991;309A:57-60. doi: 10.1007/978-1-4899-2638-8_12. Adv Exp Med Biol. 1991. PMID: 1789270 No abstract available.
Clinical relevance of biochemical modulation of 5-fluorouracil.
Peters GJ, van Groeningen CJ. Peters GJ, et al. Ann Oncol. 1991 Jul;2(7):469-80. doi: 10.1093/oxfordjournals.annonc.a057994. Ann Oncol. 1991. PMID: 1911453 Review.
Do antimetabolites interfere with the glycosylation of cellular glycoconjugates?
Peters GJ, Pinedo HM, Ferwerda W, de Graaf TW, van Dijk W. Peters GJ, et al. Eur J Cancer. 1990 Apr;26(4):516-23. doi: 10.1016/0277-5379(90)90029-s. Eur J Cancer. 1990. PMID: 2141520 Review. No abstract available.
Retention of in vivo antipyrimidine effects of Brequinar sodium (DUP-785; NSC 368390) in murine liver, bone marrow and colon cancer.
Peters GJ, Nadal JC, Laurensse EJ, de Kant E, Pinedo HM. Peters GJ, et al. Biochem Pharmacol. 1990 Jan 1;39(1):135-44. doi: 10.1016/0006-2952(90)90657-7. Biochem Pharmacol. 1990. PMID: 2153375
In vitro biochemical and in vivo biological studies of the uridine 'rescue' of 5-fluorouracil.
Peters GJ, van Dijk J, Laurensse E, van Groeningen CJ, Lankelma J, Leyva A, Nadal JC, Pinedo HM. Peters GJ, et al. Br J Cancer. 1988 Mar;57(3):259-65. doi: 10.1038/bjc.1988.56. Br J Cancer. 1988. PMID: 3355763 Free PMC article.
Induction of resistance to 2',2'-difluorodeoxycytidine in the human ovarian cancer cell line A2780.
Ruiz van Haperen VW, Veerman G, Eriksson S, Stegmann AP, Peters GJ. Ruiz van Haperen VW, et al. Among authors: peters gj. Semin Oncol. 1995 Aug;22(4 Suppl 11):35-41. Semin Oncol. 1995. PMID: 7481843
Interaction between cisplatin and gemcitabine in vitro and in vivo.
Peters GJ, Bergman AM, Ruiz van Haperen VW, Veerman G, Kuiper CM, Braakhuis BJ. Peters GJ, et al. Semin Oncol. 1995 Aug;22(4 Suppl 11):72-9. Semin Oncol. 1995. PMID: 7481849
699 results
Jump to page
Feedback